for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Pfizer to buy Medivation for $14 billion

Posted

Pfizer is paying a hefty premium for the much sought-after prostate cancer drug maker, Medivation. Fred Katayama reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up